BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33625319)

  • 1.
    Das SK; Deka SJ; Paul D; Gupta DD; Das TJ; Maravi DK; Tag H; Hui PK
    J Biomol Struct Dyn; 2022 Sep; 40(15):6857-6867. PubMed ID: 33625319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of tyrosine kinase inhibitors from Panax bipinnatifidus and Panax pseudoginseng for RTK-HER2 and VEGFR2 receptors, by in silico approach.
    Paul D; Mahanta S; Tag H; Das SK; Das Gupta D; Tanti B; Ananthan R; Das R; Jambhulkar S; Hui PK
    Mol Divers; 2022 Aug; 26(4):1933-1955. PubMed ID: 34554395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in-silico approach to identify bioactive phytochemicals from
    Sangeet S; Khan A
    J Biomol Struct Dyn; 2023 Dec; ():1-20. PubMed ID: 38109166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of phytochemicals as potential anti-breast cancer agents targeting HER2: an in-silico approach.
    Lamichhane S; Rai RP; Khatri A; Adhikari R; Shrestha BG; Shrestha SK
    J Biomol Struct Dyn; 2023 Feb; 41(3):897-911. PubMed ID: 34957911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-cancer Effect and Active Phytochemicals of Houttuynia cordata Thunb. against Human Breast Cancer Cells.
    Inthi P; Pandith H; Kongtawelert P; Banjerdpongchai R
    Asian Pac J Cancer Prev; 2023 Apr; 24(4):1265-1274. PubMed ID: 37116149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Virtual screening of antithrombotic alkaloids from Houttuynia cordata].
    Jiang YP; Chen ZY; Liu M; Liu HT; Liu S
    Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(8):1623-1634. PubMed ID: 31090327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying Active Substances and the Pharmacological Mechanism of
    Lai GH; Wang F; Nie DR; Lei SJ; Wu ZJ; Cao JX
    Evid Based Complement Alternat Med; 2022; 2022():3776340. PubMed ID: 35360660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular docking and molecular dynamic studies: screening of phytochemicals against EGFR, HER2, estrogen and NF-KB receptors for their potential use in breast cancer.
    Purawarga Matada GS; Dhiwar PS; Abbas N; Singh E; Ghara A; Das A; Bhargava SV
    J Biomol Struct Dyn; 2022 Aug; 40(13):6183-6192. PubMed ID: 33525984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Respiratory Syncytial Virus Mechanism of
    Du H; Ding J; Wang P; Zhang G; Wang D; Ma Q; Li N; Sun T
    Comb Chem High Throughput Screen; 2021; 24(8):1137-1150. PubMed ID: 32957876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of potential HER2 inhibitors from
    Balogun TA; Iqbal MN; Saibu OA; Akintubosun MO; Lateef OM; Nneka UC; Abdullateef OT; Omoboyowa DA
    J Biomol Struct Dyn; 2022; 40(23):12772-12784. PubMed ID: 34514973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational investigation of phytochemicals from
    Omoboyowa DA; Singh G; Fatoki JO; Oyeneyin OE
    J Biomol Struct Dyn; 2023; 41(12):5568-5582. PubMed ID: 35773777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular docking and dynamic simulation to identify potential phytocompound inhibitors for EGFR and HER2 as anti-breast cancer agents.
    Prabhavathi H; Dasegowda KR; Renukananda KH; Karunakar P; Lingaraju K; Raja Naika H
    J Biomol Struct Dyn; 2022 Jul; 40(10):4713-4724. PubMed ID: 33345701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of HER2 inhibitors from curcumin derivatives using combination of
    Saibu OA; Singh G; Olugbodi SA; Oluwafemi AT; Ajayi TM; Hammed SO; Oladipo OO; Odunitan TT; Omoboyowa DA
    J Biomol Struct Dyn; 2023; 41(21):12328-12337. PubMed ID: 36752338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational analyses of curcuminoid analogs against kinase domain of HER2.
    Yim-im W; Sawatdichaikul O; Semsri S; Horata N; Mokmak W; Tongsima S; Suksamrarn A; Choowongkomon K
    BMC Bioinformatics; 2014 Aug; 15(1):261. PubMed ID: 25089037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potentials of Houttuynia cordata Thunb. against inflammation and oxidative stress: A review.
    Shingnaisui K; Dey T; Manna P; Kalita J
    J Ethnopharmacol; 2018 Jun; 220():35-43. PubMed ID: 29605674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of
    Subhawa S; Chewonarin T; Banjerdpongchai R
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32155880
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytotoxicity, anti-angiogenic, anti-tumor and molecular docking studies on phytochemicals isolated from Polygonum hydropiper L.
    Mahnashi MH; Alqahtani YS; Alyami BA; Alqarni AO; Ullah F; Wadood A; Sadiq A; Shareef A; Ayaz M
    BMC Complement Med Ther; 2021 Sep; 21(1):239. PubMed ID: 34560864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-Based Pharmacophore Modeling, Molecular Docking, and Molecular Dynamic Studies of Dual Tyrosine Kinase Inhibitor of EGFR and VEGFR2.
    Sangande F; Julianti E; Tjahjono DH
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Houttuynia cordata Thunb Promotes Activation of HIF-1A-FOXO3 and MEF2A Pathways to Induce Apoptosis in Human HepG2 Hepatocellular Carcinoma Cells.
    Kim JM; Hwang IH; Jang IS; Kim M; Bang IS; Park SJ; Chung YJ; Joo JC; Lee MG
    Integr Cancer Ther; 2017 Sep; 16(3):360-372. PubMed ID: 27698266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of octahydropyrrolo [3,2-b] pyridin derivative as a highly selective Type I inhibitor of FGFR3 over VEGFR2 by high-throughput virtual screening.
    Wang X; Ye CH; Li EM; Xu LY; Lin WQ; Chen GH
    J Cell Biochem; 2023 Feb; 124(2):221-238. PubMed ID: 36502529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.